Beverly JCG Provides Updates on Recent Deals; Shares Fall 10%

Beverly JCG (SGX:9QX) provided updates on the company's recent transactions, which include acquisitions, share issuance, debt capitalizations and share subscription, a filing with the Singapore Exchan

MT NewswiresMay 17 00:02 ET

Beverly JCG's Q1 Attributable Loss Widens on Lower Revenue

Beverly JCG (SGX:9QX) posted an attributable loss of SG$597,000 in the first quarter, 11% wider compared with SG$537,000 a year earlier, according to a Tuesday filing with the Singapore Exchange. Loss

MT NewswiresMay 14 19:49 ET

Beverly JCG Enters Debt Capitalization Agreement; Shares Surge 8%

Beverly JCG (SGX:9QX) entered into a debt capitalization agreement with Yap Mee Lee for the conversion of capitalized debt of SG$100,000 into conversion shares and part payment of salaries of SG$80,42

MT NewswiresApr 24 23:16 ET

Beverly JCG to Pay Sponsor With New Shares Worth SG$75,000

Beverly JCG (SGX:9QX) will issue 5 million new ordinary shares worth SG$75,000 to its continuing sponsor, Evolve Capital Advisory, as part of its payment for professional fees, according to a Singapor

MT NewswiresApr 17 22:40 ET

Beverly JCG to Acquire Aesthetics Clinic; Shares Surge 8%

Beverly JCG (SGX:9QX) entered into a sale and purchase agreement for the acquisition of BK Aesthetics Clinic for a consideration of SG$117,026, through a share exchange valued at SG$0.015 per share, a

MT NewswiresApr 12 00:01 ET

Beverly JCG's Q4 2023 Attributable Loss Widens; Shares Slide 5%

Beverly JCG (SGX:9QX) widened its attributable loss to equity holders to SG$561,000 in the fourth quarter of 2023, from SG$337,000 in the year-ago period. Loss per share for Q4 2023 came in at SG$0.00

MT NewswiresFeb 28 23:57 ET